Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 2
1990 1
1992 1
1994 1
1998 1
1999 1
2001 2
2002 3
2004 1
2005 2
2006 1
2007 1
2008 1
2009 2
2010 3
2011 2
2012 2
2013 2
2014 2
2015 1
2016 2
2017 4
2018 2
2019 2
2020 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Small Intestinal Adenocarcinoma"
Page 1
Outcomes of Metastatic and Unresectable Small Bowel Adenocarcinoma in Japan According to the Treatment Strategy: A Nationwide Observational Study.
Nishikawa Y, Horimatsu T, Oka S, Yamada T, Mitsui K, Yamamoto H, Takahashi K, Shiomi A, Hotta K, Takeuchi Y, Kuwai T, Ishida F, Kudo SE, Saito S, Ueno M, Sunami E, Yamano T, Itabashi M, Ohtsuka K, Kinugasa Y, Matsumoto T, Sugai T, Uraoka T, Kurahara K, Yamaguchi S, Kato T, Okajima M, Kashida H, Fujita F, Ikematsu H, Ito M, Esaki M, Kawai M, Yao T, Hamada M, Koda K, Fukai Y, Komori K, Saitoh Y, Kanemitsu Y, Takamaru H, Yamada K, Nozawa H, Takayama T, Togashi K, Shinto E, Torisu T, Toyoshima A, Ohmiya N, Kato T, Otsuji E, Nagata S, Hashiguchi Y, Sugihara K, Ajioka Y, Tanaka S. Nishikawa Y, et al. JCO Glob Oncol. 2024 Feb;10:e2300392. doi: 10.1200/GO.23.00392. JCO Glob Oncol. 2024. PMID: 38330276 Free PMC article.
PURPOSE: Limited information is available regarding the characteristics and outcomes of stage IV small bowel adenocarcinoma (SBA) in Japan. This study examined the clinical and pathological characteristics and outcomes according to the treatment strategies in …
PURPOSE: Limited information is available regarding the characteristics and outcomes of stage IV small bowel adenocarcinoma (S …
Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
Gangi A, Anaya DA. Gangi A, et al. Curr Treat Options Oncol. 2020 Aug 29;21(11):88. doi: 10.1007/s11864-020-00784-2. Curr Treat Options Oncol. 2020. PMID: 32862334 Review.
Small bowel neuroendocrine tumors (SB NETs) are increasing in frequency and becoming more common in surgical practice. ...Unlike other gastrointestinal malignancies, aggressive surgical management of these patients, even in the context of unresectable metastatic dis …
Small bowel neuroendocrine tumors (SB NETs) are increasing in frequency and becoming more common in surgical practice. ...Unlike othe …
Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.
Nishikawa Y, Hoshino N, Horimatsu T, Funakoshi T, Hida K, Sakai Y, Muto M, Nakayama T. Nishikawa Y, et al. Int J Clin Oncol. 2020 Aug;25(8):1441-1449. doi: 10.1007/s10147-020-01703-z. Epub 2020 May 24. Int J Clin Oncol. 2020. PMID: 32448950
BACKGROUND: There is no standard chemotherapy available for unresectable or metastatic small bowel adenocarcinoma (SBA) because of its rarity. ...The included studies were prospective randomized, nonrandomized, or observational studies. Risk of bias wa …
BACKGROUND: There is no standard chemotherapy available for unresectable or metastatic small bowel adenocarcinoma (SBA) …
Small bowel adenocarcinoma of the jejunum: a case report and literature review.
Li J, Wang Z, Liu N, Hao J, Xu X. Li J, et al. World J Surg Oncol. 2016 Jul 4;14(1):177. doi: 10.1186/s12957-016-0932-3. World J Surg Oncol. 2016. PMID: 27402105 Free PMC article. Review.
BACKGROUND: In practice, small bowel cancer is a rare entity. The most common histologic subtype is adenocarcinoma. Adenocarcinoma of the small bowel (SBA) is challenging to diagnose, often presents at a late stage and has a poor prognosis. ...
BACKGROUND: In practice, small bowel cancer is a rare entity. The most common histologic subtype is adenocarcinoma. Adenoca …
Clinicopathological features and treatment outcomes of metastatic or locally unresectable small bowel adenocarcinoma.
Li X, Ying H, Cheng Y, Zhao L, Zhao S, Bai C, Zhou J. Li X, et al. J BUON. 2019 Nov-Dec;24(6):2539-2545. J BUON. 2019. PMID: 31983130 Free article.
PURPOSE: Small bowel adenocarcinoma (SBA) is an uncommon malignancy with poor prognosis and therefore difficult to study. ...The survival of three metastatic patients was 52-96 months after combination treatment of chemotherapy, resection of primary tumor and metast …
PURPOSE: Small bowel adenocarcinoma (SBA) is an uncommon malignancy with poor prognosis and therefore difficult to study. ...T …
Interventional endoscopy, neoadjuvant therapy and the gastroenterologist.
Snady H. Snady H. Hematol Oncol Clin North Am. 2002 Feb;16(1):53-79. doi: 10.1016/s0889-8588(01)00010-7. Hematol Oncol Clin North Am. 2002. PMID: 12063829 Review.
EUS-guided FNA represents a significant improvement over CT scan-guided FNA to make a tissue diagnosis. Small pancreatic masses that would be resected regardless of whether an FNA is positive or negative require only an EUS evaluation to establish an early resectable stage …
EUS-guided FNA represents a significant improvement over CT scan-guided FNA to make a tissue diagnosis. Small pancreatic masses that …
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O, Elsayed Z, Elhalawani H. Abdel-Rahman O, et al. Cochrane Database Syst Rev. 2018 Apr 6;4(4):CD011746. doi: 10.1002/14651858.CD011746.pub2. Cochrane Database Syst Rev. 2018. PMID: 29624208 Free PMC article. Review.
The trial did not report data for serious adverse events, quality of life, or tumour response outcomes. ...Gemcitabine-based regimens showed an increase in non-serious adverse events (particularly haematological toxicities). Further randomised clinical trials …
The trial did not report data for serious adverse events, quality of life, or tumour response outcomes. ...Gemcitabine-based regimens …
A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
Makino S, Takahashi H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Ikenaga M, Murata K, Yamamoto H, Doki Y, Mori M, Mizushima T. Makino S, et al. Anticancer Res. 2017 Mar;37(3):1495-1500. doi: 10.21873/anticanres.11476. Anticancer Res. 2017. PMID: 28314324
BACKGROUND: Small bowel adenocarcinoma (SBA) is rare. For unresectable or recurrent SBA, systemic treatment is the only potentially promising option. ...The 5-year relapse-free survival of patients with curatively resected (R0 or R1) SBA (n=6) was 45%. Patien …
BACKGROUND: Small bowel adenocarcinoma (SBA) is rare. For unresectable or recurrent SBA, systemic treatment is the only …
Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater.
Bakkevold KE, Pettersen A, Arnesjø B, Espehaug B. Bakkevold KE, et al. Br J Surg. 1990 Jul;77(7):725-30. doi: 10.1002/bjs.1800770704. Br J Surg. 1990. PMID: 2200555 Clinical Trial.
Between 1984 and 1987, 176 Norwegian patients with histologically verified unresectable pancreatic adenocarcinoma were randomized to double-blind treatment with oral tamoxifen (30 mg daily; 48 men and 44 women) or placebo (47 men and 37 women). ...No male pat …
Between 1984 and 1987, 176 Norwegian patients with histologically verified unresectable pancreatic adenocarcinoma were rand …
Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK, Sause WT, Hazard LJ, Belnap LP, Noyes RD. O'Connor JK, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1060-6. doi: 10.1016/j.ijrobp.2005.03.036. Epub 2005 Jun 22. Int J Radiat Oncol Biol Phys. 2005. PMID: 15978737
PURPOSE: To evaluate a single institution's experience with intraoperative radiation therapy (IORT) in combination with attempted surgical resection for pancreatic and periampullary adenocarcinoma. METHODS AND MATERIALS: From May 1986 until June 2001, 77 patients at LDS Ho …
PURPOSE: To evaluate a single institution's experience with intraoperative radiation therapy (IORT) in combination with attempted surgical r …
43 results